Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med 1997;337:396-407. https://doi.org/10.1056/NEJM199708073370606

Reinehr T, Hinney A, de Sousa G, Austrup F, Hebebrand J, Andler W. Definable somatic disorders in overweight children and adolescents. J Pediatr 2007;150:618-22, 622.e1-5. https://doi.org/10.1016/j.jpeds.2007.01.042

Kim BY, Kang SM, Kang JH, et al. 2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea. J Obes Metab Syndr 2021;30:81-92. https://doi.org/10.7570/jomes21022

Chiumello G, Manzoni P, Beccaria L, Simone P. Secondary obesity. Nutr Res 1993;13(Suppl 1):S109-16. https://doi.org/10.1016/S0271-5317(05)80288-X

Allen G, Safranek S. FPIN's clinical inquiries. Secondary causes of obesity. Am Fam Physician 2011;83:972-3.

Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: an intriguing link. Indian J Endocrinol Metab 2016;20:554-7. https://doi.org/10.4103/2230-8210.183454

Biondi B. Thyroid and obesity: an intriguing relationship. J Clin Endocrinol Metab 2010;95:3614-7. https://doi.org/10.1210/jc.2010-1245

Roberts CG, Ladenson PW. Hypothyroidism. Lancet 2004;363:793-803. https://doi.org/10.1016/S0140-6736(04)15696-1

Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am 2012;96:203-21. https://doi.org/10.1016/j.mcna.2012.01.005

Persani L. Clinical review: Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 2012;97:3068-78. https://doi.org/10.1210/jc.2012-1616

Persani L, Bonomi M, Radin R, Beck-Peccoz P. Diagnostic and therapeutic challenges of acquired thyrotropic deficiency. Ann Endocrinol (Paris) 2012;73:138-40. https://doi.org/10.1016/j.ando.2012.04.004

Loriaux DL. Diagnosis and differential diagnosis of Cushing's syndrome. N Engl J Med 2017;376:1451-9. https://doi.org/10.1056/NEJMra1505550

Fukuhara D, Takiura T, Keino H, Okada AA, Yan K. Iatrogenic Cushing's syndrome due to topical ocular glucocorticoid treatment. Pediatrics 2017;139:e20161233. https://doi.org/10.1542/peds.2016-1233

Scutelnicu A, Panaitescu AM, Ciobanu AM, et al. Iatrogenic Cushing's syndrome as a consequence of nasal use of Betamethasone spray during pregnancy. Acta Endocrinol (Buchar) 2020;16:511-7. https://doi.org/10.4183/aeb.2020.511

Joshi RR, Maresh A. Iatrogenic Cushing's syndrome and adrenal insufficiency in infants on intranasal dexamethasone drops for nasal obstruction- case series and literature review. Int J Pediatr Otorhinolaryngol 2018;105:123-6. https://doi.org/10.1016/j.ijporl.2017.11.007

Hochberg I, Hochberg Z. Hypothalamic obesity. Endocr Dev 2010;17:185-96. https://doi.org/10.1159/000262539

Muller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 2016;23:81-9. https://doi.org/10.1097/MED.0000000000000214

van Santen SS, Wolf P, Kremenevski N, et al. Bariatric surgery for hypothalamic obesity in craniopharyngioma patients: a retrospective, matched case-control study. J Clin Endocrinol Metab 2021;106:e4734-45.

Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord 1999;23:260-71. https://doi.org/10.1038/sj.ijo.0800807

Gasco V, Prodam F, Grottoli S, et al. GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting doses. Eur J Endocrinol 2013;168:R55-66. https://doi.org/10.1530/EJE-12-0563

Lubrano C, Tenuta M, Costantini D, et al. Severe growth hormone deficiency and empty sella in obesity: a cross-sectional study. Endocrine 2015;49:503-11. https://doi.org/10.1007/s12020-015-0530-0

Diez JJ, Sangiao-Alvarellos S, Cordido F. Treatment with growth hormone for adults with growth hormone deficiency syndrome: benefits and risks. Int J Mol Sci 2018;19:893. https://doi.org/10.3390/ijms19030893

Boguszewski CL. Update on GH therapy in adults. F1000Res 2017;6:2017. https://doi.org/10.12688/f1000research.12057.1

Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8. https://doi.org/10.1038/43185

Licinio J, Caglayan S, Ozata M, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A 2004;101:4531-6. https://doi.org/10.1073/pnas.0308767101

Gregoric N, Groselj U, Bratina N, et al. Two cases with an early presented proopiomelanocortin deficiency- a long-term follow-up and systematic literature review. Front Endocrinol (Lausanne) 2021;12:689387. https://doi.org/10.3389/fendo.2021.689387

Aykut A, Ozen S, Goksen D, et al. Melanocortin 4 receptor (MC4R) gene variants in children and adolescents having familial early-onset obesity: genetic and clinical characteristics. Eur J Pediatr 2020;179:1445-52. https://doi.org/10.1007/s00431-020-03630-7

Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 2004;15:12-20. https://doi.org/10.1016/j.tem.2003.11.003

Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med 1981;304:325-9. https://doi.org/10.1056/NEJM198102053040604

Ledbetter DH, Mascarello JT, Riccardi VM, Harper VD, Airhart SD, Strobel RJ. Chromosome 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases. Am J Hum Genet 1982;34:278-85.

Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet 2010;375:1737-48. https://doi.org/10.1016/S0140-6736(10)60171-7

Stipancic G, Sepec MP. Secondary causes of obesity in children and adolescents. Central Eur J Paed 2018;14:1-11. https://doi.org/10.5457/p2005-114.193

Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-96. https://doi.org/10.1176/ajp.156.11.1686

Lazzaroni E, Ben Nasr M, Loretelli C, et al. Anti-diabetic drugs and weight loss in patients with type 2 diabetes. Pharmacol Res 2021;171:105782. https://doi.org/10.1016/j.phrs.2021.105782

Phung OJ, Scholle JM, Talwar M, Coleman CI. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA 2010;303:1410-8. https://doi.org/10.1001/jama.2010.405

Rosenthal NE, Genhart M, Jacobsen FM, Skwerer RG, Wehr TA. Disturbances of appetite and weight regulation in seasonal affective disorder. Ann N Y Acad Sci 1987;499:216-30.

Aguera Z, Lozano-Madrid M, Mallorqui-Bague N, Jimenez-Murcia S, Menchon JM, Fernandez-Aranda F. A review of binge eating disorder and obesity. Neuropsychiatr 2021;35:57-67. https://doi.org/10.1007/s40211-020-00346-w

van der Valk ES, van den Akker ELT, Savas M, et al. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obes Rev 2019;20:795-804. https://doi.org/10.1111/obr.12836